{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n In the study summarized in Abstract"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ", the authors investigated pharmacogenomic markers associated with anti‐TNF treatment response in rheumatoid arthritis patients by identifying 25 single nucleotide polymorphisms that map to genes involved in T cell function, NFκB, and TNF signaling pathways. It is important to note that LINC01387 was not mentioned or analyzed in this investigation. Consequently, no functional insights regarding LINC01387 in the context of anti‐TNF treatment response or rheumatoid arthritis are provided by this study.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "S Bek, A B Bojesen, J V Nielsen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenomics J (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/tpj.2017.26"}], "href": "https://doi.org/10.1038/tpj.2017.26"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28607508"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28607508"}]}]}]}